Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bootsma

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1995
Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosusI E Coremans, P E Spronk, H Bootsma, et al.
Arthritis and Rheumatism|October 31, 2009
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndromeJ Pijpe, J M Meijer, H Bootsma, et al.
Arthritis and Rheumatism|February 5, 2010
Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trialJ M Meijer, P M Meiners, A Vissink, et al.
Journal of Clinical Psychology in Medical Settings|September 10, 2015
Crying Without Tears: Dimensions of Crying and Relations With Ocular Dryness and Mental Well-Being in Patients With Sjögren's SyndromeN van Leeuwen, E R Bossema, R R Vermeer, et al.
Clinical and Experimental Rheumatology|April 21, 2011
Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndromeA Hartkamp, R Geenen, A A Kruize, et al.
British Journal of Rheumatology|December 1, 1994
Long-term follow-up of 46 patients with anti-(U1)snRNP antibodiesF H van den Hoogen, P E Spronk, A M Boerbooms, et al.
Rheumatology (Oxford, England)|June 6, 2002
The measurement of serum salivary isoamylase as a clinical parameter in Sjögren's syndromeW W I Kalk, A Vissink, J C J M Swaanenburg, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 12, 2020
Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spotsXinying Hong, Jessica Daiker, Martin Sadilek, et al.
Diabetes Care|September 7, 2007
Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuriaAdrienne A M Zandbergen, Liffert Vogt, Dick de Zeeuw, et al.
Arthritis and Rheumatism|January 13, 2011
B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled studyW H Abdulahad, J M Meijer, F G M Kroese, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1995
Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosusI E Coremans, P E Spronk, H Bootsma, et al.
Arthritis and Rheumatism|October 31, 2009
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndromeJ Pijpe, J M Meijer, H Bootsma, et al.
Arthritis and Rheumatism|February 5, 2010
Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trialJ M Meijer, P M Meiners, A Vissink, et al.
Journal of Clinical Psychology in Medical Settings|September 10, 2015
Crying Without Tears: Dimensions of Crying and Relations With Ocular Dryness and Mental Well-Being in Patients With Sjögren's SyndromeN van Leeuwen, E R Bossema, R R Vermeer, et al.
Clinical and Experimental Rheumatology|April 21, 2011
Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndromeA Hartkamp, R Geenen, A A Kruize, et al.
British Journal of Rheumatology|December 1, 1994
Long-term follow-up of 46 patients with anti-(U1)snRNP antibodiesF H van den Hoogen, P E Spronk, A M Boerbooms, et al.
Rheumatology (Oxford, England)|June 6, 2002
The measurement of serum salivary isoamylase as a clinical parameter in Sjögren's syndromeW W I Kalk, A Vissink, J C J M Swaanenburg, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 12, 2020
Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spotsXinying Hong, Jessica Daiker, Martin Sadilek, et al.
Diabetes Care|September 7, 2007
Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuriaAdrienne A M Zandbergen, Liffert Vogt, Dick de Zeeuw, et al.
Arthritis and Rheumatism|January 13, 2011
B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled studyW H Abdulahad, J M Meijer, F G M Kroese, et al.
Pageof 11